Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bicalutamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 77 for your search:
Start Over
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: D6876C00001, NCT00293696
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 40 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO108943, NCT00470834
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9601, CDR0000065158, RTOG-R9601, NCT00002874
Hormone Therapy in Treating Patients With Advanced Prostate Cancer
Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: EORTC-22961, EORTC-GU-22961, NCT00003026
Phase III Randomized Study of Bicalutamide versus Placebo in Combination with Castration as Second Line Therapy in Patients with Asymptomatic Metastatic Prostate Cancer (Summary Last Modified 01/2000)
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-98092, ZENECA-7054US/0007, NCI-G99-1494
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-9902, CDR0000067250, RTOG-DEV-1020, NCT00004054
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9910, CDR0000067635, NCT00005044
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor: Other
Protocol IDs: CDR0000068749, EORTC-22991, NCT00021450
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0011, CDR0000068868, RTOG-DEV-1037, CAN-NCIC-PR9, PR9, NCT00023829
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
Phase III Randomized Comparison of Casodex vs ZDX or Orchiectomy in Patients with Previously Untreated Stage D2 Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: UCLA-9002048, NCI-V90-0176
Phase III Randomized Study of Orchiectomy vs Casodex (ICI 176334) in Patients with Metastatic Prostate Cancer (Summary Last Modified 03/92)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CRC-TU-PR3003, EU-90044
Phase III Randomized Trial of Two Different Doses of Casodex (100 vs 150 mg/day) vs Orchiectomy or Medical Castration with ZDX in Patients with Advanced Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CRC-TU-PR3005, EU-92015
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 03-040, P30CA008748, MSKCC-03040, NCT00067015
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353209, U10CA031946, CALGB-90202, CAN-NCIC-PRC2, ECOG-CALGB-90202, SWOG-CALGB-90202, NCT00079001
Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer
Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 7054IT/0003, NCT00233610
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
Phase: Phase III
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-4, NCT00243646
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0521, CDR0000462375, NCI-2009-00728, NCT00288080
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0534, CDR0000577574, NCI-2009-00733, NCT00567580
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS30, 2008-005232-33, NCT00833248
Start Over